Loring Wolcott & Coolidge Fiduciary Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.16M | Sell |
|
|||||
|
2025
Q1 | $7.42M | Buy |
|
|||||
|
2024
Q4 | $9.95M | Buy |
|
|||||
|
2024
Q3 | $3.66M | Sell |
|
|||||
|
2024
Q2 | $4.62M | Buy |
|
|||||
|
2024
Q1 | $2.54M | Sell |
|
|||||
|
2023
Q4 | $2.34M | Hold |
|
|||||
|
2023
Q3 | $2.06M | Sell |
|
|||||
|
2023
Q2 | $1.67M | Hold |
|
|||||
|
2023
Q1 | $1.64M | Sell |
|
|||||
|
2022
Q4 | $1.48M | Hold |
|
|||||
|
2022
Q3 | $1.09M | Hold |
|
|||||
|
2022
Q2 | $1.22M | Hold |
|
|||||
|
2022
Q1 | $1.22M | Hold |
|
|||||
|
2021
Q4 | $1.23M | Sell |
|
|||||
|
2021
Q3 | $1.07M | Sell |
|
|||||
|
2021
Q2 | $1.01M | Sell |
|
|||||
|
2021
Q1 | $819K | Sell |
|
|||||
|
2020
Q4 | $850K | Buy |
|
|||||
|
2020
Q3 | $826K | Hold |
|
|||||
|
2020
Q2 | $779K | Buy |
|
|||||
|
2020
Q1 | $686K | Sell |
|
|||||
|
2019
Q4 | $931K | Sell |
|
|||||
|
2019
Q3 | $1.51M | Sell |
|
|||||
|
2019
Q2 | $1.85M | Sell |
|
|||||
|
2019
Q1 | $3.49M | Sell |
|
|||||
|
2018
Q4 | $27.5M | Sell |
|
|||||
|
2018
Q3 | $31.5M | Sell |
|
|||||
|
2018
Q2 | $33.5M | Sell |
|
|||||
|
2018
Q1 | $40.5M | Sell |
|
|||||
|
2017
Q4 | $56M | Sell |
|
|||||
|
2017
Q3 | $51.9M | Sell |
|
|||||
|
2017
Q2 | $47.5M | Sell |
|
|||||
|
2017
Q1 | $44.9M | Sell |
|
|||||
|
2016
Q4 | $52.1M | Sell |
|
|||||
|
2016
Q3 | $72.4M | Buy |
|
|||||
|
2016
Q2 | $92.2M | Sell |
|
|||||
|
2016
Q1 | $93.7M | Sell |
|
|||||
|
2015
Q4 | $101M | Buy |
|
|||||
|
2015
Q3 | $93.3M | Hold |
|
|||||
|
2015
Q2 | $93.3M | Sell |
|
|||||
|
2015
Q1 | $93.6M | Sell |
|
|||||
|
2014
Q4 | $74.6M | Sell |
|
|||||
|
2014
Q3 | $85.5M | Sell |
|
|||||
|
2014
Q2 | $83.4M | Sell |
|
|||||
|
2014
Q1 | $83M | Buy |
|
|||||
|
2013
Q4 | $67M | Buy |
|
|||||
|
2013
Q3 | $59.8M | Buy |
|
|||||
|
2013
Q2 | $53.1M | Buy |
|